CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression [3]

Leukemia

Volumn 18, Issue 3, 2004, Pages 649-650

  McCabe, D ^a   Bacon, L ^a   O'Regan, K ^a   Condron, C ^a   O'Donnell, J R ^a   Murphy, Philip T ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CD19 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; ISOPROTEIN; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; SCATTER FACTOR; VASCULOTROPIN; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CD38 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; B CELL LEUKEMIA; BLOOD CELL COUNT; BLOOD LEVEL; CANCER STAGING; CELL CLONE; CELL GROWTH; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOTHESIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKEMIA CELL; MALE; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; B LYMPHOCYTE; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED;

ADP-RIBOSYL CYCLASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD38; B-LYMPHOCYTES; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1542503797     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403282     Document Type: Letter

References (8)

1. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847.
2. Molica S. Angiogenesis in B-cell chronic lymphocytic leukemia: Methods of study, clinical significance and prognostic implications. Leuk Lymphoma 2001; 42: 603-607.
3. Molica S, Vacca A, Ribatti D, Cuneo A, Cavazzini F, Levato D et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 2002; 100: 3344-3351.
4. Molica S, Santoro R, Digiesi G, Dattilo A, Levato D, Muleo G. Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukemia cells. Haematologica 2000; 85: 1106-1108.
5. Aguayo A, O'Brien S, Keating M, Manshouri T, Gidel C, Barlogie B et al. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia. Blood 2000; 96: 768-770.
6. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al. Angiogenesis in acute and chronic leukemias and myelodys-plastic syndromes. Blood 2000; 96: 2240-2245.
7. Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999; 59: 728-733.
8. Bairey O, Zimra Y, Shaklai M, Rabizadeh E. Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia. Br J Haematol 2001; 113: 400-406.